Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-06-01 to 2025-05-31
Current total value of award: $1121090
Description: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS-- TARGETING THE PARP PATHWAY FOR THE PREVENTION OF BREAST CANCER